Please use this identifier to cite or link to this item:
Title: Frailty, MRI, and FDG-PET Measures in an Australian Memory Clinic Cohort
Austin Authors: Jordan, Nan;Gvalda, Matthew;Cody, Ross;Galante, Olivia;Haywood, Cilla J ;Yates, Paul A 
Affiliation: Geriatric Medicine
Department of Medicine, Eastern Health, Box Hill, VIC, Australia
Medicine (University of Melbourne)
Neuropathology and Neurodegeneration Laboratory, Florey Neuroscience Institute, Heidelberg, VIC, Australia
Issue Date: 14-Jan-2021
Date: 2021-01-14
Publication information: Frontiers in Medicine 2021; 7: 788
Abstract: Given that the global population is aging, the number of age-related syndromes, such as frailty, is expected to rise in conjunction. Frailty is characterized by the loss of homeostatic reserve, rendering the individual vulnerable to poor health outcomes. Many biological mechanisms have been proposed to contribute to frailty. However, few studies have assessed the associations between frailty and brain diseases or neuroimaging biomarkers. Aims: The aims of this study were to measure the prevalence of frailty in a memory clinic and to examine associations between frailty and brain changes found on magnetic resonance imaging (MRI) and 18-F deoxyglucose (FDG) positron emission tomography (PET) in memory clinic attendees. Methods: A 54-items Frailty Index was retrospectively assessed for all clinic attendees from 2014. Frailty was defined as FI > 0.25. MR images were analyzed for stroke, cerebral small vessel disease [CSVD, including cerebral microbleeds (CMBs), cortical superficial siderosis (CSS), and white matter hyperintensity (WMH)], and neurodegenerative changes [MRI: mesial temporal atrophy (MTA), FDG-PET: regional hypometabolism], blind to clinical findings. Results: There were 209 clinic attendees in 2014, of whom 121 had MRI performed. The prevalence of frailty (using FI) in the memory clinic in 2014 was 38.3% overall (patients without MRI: 43.2%, patients with MRI 34.7%, p = 0.25). Frailty was associated with presence of deep WMH, increased severity of periventricular WMH, and presence of CSS, but not neurodegeneration markers (MTA atrophy/FDG-PET hypometabolism). Conclusion: The findings support the idea that previously reported associations between frailty and imaging evidence of CSVD in other cohorts are also relevant to the Australian clinic setting. Given that a large proportion of memory clinic attendees are frail, there may be opportunities for interventions to reduce preventable adverse health outcomes, such as falls and fractures, and reduce the prevalence and impact of frailty in this cohort.
DOI: 10.3389/fmed.2020.578243
Journal: Frontiers in Medicine
PubMed URL: 33521008
Type: Journal Article
Subjects: Alzheimer's disease
cerebrovascular disease
magnetic resonance imaging (MRI)
memory clinic
neurodegenerative disease
positron emission tomography (PET)
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on May 30, 2024


checked on May 30, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.